Dipsar 5/160, Dipsar 10/160 5 mg and 160 mg, 10 mg and 160 mg Film-coated tablets.
PDF Leaflet Revision Date: 12 October 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate essential hypertension.
Dosage (summary)
One tablet daily; no adjustment for elderly or mild/moderate renal impairment.
Onset of Action / Duration
Onset: 2 hours, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; may cause fetal harm.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
- CYP3A4 inhibitors
Contraindications
- Hypersensitivity
- Severe renal impairment
- Pregnancy
- Lactation
Common side effects
- Dizziness
- Fatigue
- Hypotension
- Headache
- Oedema
Counselling Points
- Take with water
- Monitor blood pressure
- Avoid potassium supplements
Serious warnings
- Risk of hypotension
- Angioedema
- Dual blockade of RAAS contraindicated
Important Disclaimer
The Dipsar 5/160, Dipsar 10/160 5 mg and 160 mg, 10 mg and 160 mg Film-coated tablets. professional information leaflet below is the property of Novagen Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
